U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537075) titled 'An Open Label Extension of SKY-0515 in Participants With Huntington's Disease' on April 03.
Brief Summary: The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve the symptoms of participants with HD. This study includes men and women aged 25 and older who have HD confirmed by genetic testing and meet certain requirements for physical ability and independence.
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Huntington's Disease (HD)
Intervention:
DRUG: SKY-0515
Study Drug Name (INN): SKY-0515 Type: Drug (s...